Search
for
Did you mean Keratoacanthoma?
Sort by
Research 30 of 177
- Spontaneous tumour regression in keratoacanthomas is driven by Wnt/retinoic acid signalling cross-talk
- Keratoacanthoma of the lip: A case report with emphasis on histogenesis
- A rare case of multiple keratoacanthomas treated with oral acitretin and intralesional methotrexate
- Role of the Wnt signaling pathway in keratoacanthoma
- IMMUNOHISTOCHEMICAL EXPRESSION OF KERATIN PROTEINS IN KERATOACANTHOMAS OF THE SKIN
- 43853 Case of Reactive Keratoacanthomas arising Eight Years After Multicolored Tattoo Placement
- Hair sheath keratins in follicular tumors. (5). Identification of hair sheath keratins in keratoacanthoma; Histopathological hair sheath structures in the tumor and their significance as differential histopathological criteria from squamous cell carcinoma.
- The keratoacanthoma: A review
- Keratoacanthoma and other types of squamous cell carcinoma with crateriform architecture: Classification and identification
- The changes in the expression levels of follicular markers in keratoacanthoma depend on the stage: keratoacanthoma is a follicular neoplasm exhibiting infundibular/isthmic differentiation without expression of CK15
- Intralesional therapy for the treatment of keratoacanthoma
- Histogenesis of keratoacanthoma: histochemical and immunohistochemical study
- CLINICAL-MORPHOLOGICAL FEATURES AND NEW ASPECTS OF KERATOACANTHOMA TREATMENT:NARRATIVE REVIEW
- Solitary Keratoacanthoma of the Scalp: A Case Report
- Cytologic Aspect of Keratoacanthoma with Granulomatous Inflammation in a Dog
- Giant Keratoacanthoma Mimicking Squamous Cell Carcinomain a Patient with Chronic Myeloid Leukemia
- 129 Genetic transformation of keratoacanthoma-type cutaneous squamous cell carcinoma following intralesional chemotherapy
- p63 expression in normal skin and usual cutaneous carcinomas
- Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Perspectives on Dermatopathology
- Importance of vascular patterns in the dermoscopy recognition of cutaneous tumors
- The influence of the demodex mite on the morphological picture of eyelid papilloma
- Rapidly growing hand nodule
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Controversial Concepts
- Correction: RASopathic Skin Eruptions during Vemurafenib Therapy
- Data from Elevated Cutaneous Smad Activation Associates with Enhanced Skin Tumor Susceptibility in Organ Transplant Recipients